Repercussão da COVID-19 em crianças e adolescentes: nova inflamação multissistêmica ou desencadeamento da doença de Kawasaki?
COVID-19 repercussion in children and adolescents: a new multisystem inflammation or a Kawasaki disease trigger?
Andréia Pepe Carneiro; Ana Carolina Macedo Gaiatto; Ana Luiza Moraes Ferraz; Bruno Soubihe de Gáspari; Raphael Badessa Jacomini; Thaciane Alkmim Bibo; Neusa Falbo Wandalsen
Resumo
A doença causada pelo novo coronavírus (COVID-19) teve início em dezembro de 2019 na China e rapidamente adquiriu grande importância epidemiológica, com um crescente número de casos e mortes no Brasil e no mundo. Entre os diversos estudos sobre a doença causada pelo SARS-CoV-2, foram relatados casos de crianças infectadas que apresentaram inflamação multissistêmica, mimetizando a doença de Kawasaki, o que instigou a possibilidade de uma associação entre esta e a COVID-19. O presente artigo de revisão visa destacar esta nova possibilidade diagnóstica, discutindo principalmente os sintomas, exames laboratoriais e a epidemiologia que podem diferenciar a síndrome inflamatória multissistêmica em crianças (MIS-C) como decorrente da COVID19 ou desencadeante da doença de Kawasaki. O banco de dados eletrônico PubMed foi utilizado para a pesquisa de artigos originais e de revisão de 2020 e 2021, selecionados de acordo com critérios de atualidade e menção a descritores científicos como infecções por coronavírus, síndrome de linfonodos mucocutâneos e inflamação. A revisão dos sintomas da MIS-C e achados de exames laboratoriais relacionados à COVID-19 foi feita por meio de artigos com estudos realizados com mais de 10 pacientes. Entre os principais resultados obtidos tem-se a diferença entre a faixa etária e etnia acometidas, presença de sintomas gastrointestinais, mecanismos de lesão cardíaca envolvidos e alterações de exames laboratoriais na doença de Kawasaki e na MIS-C. Assim, a conclusão é que a MIS-C está relacionada à infecção prévia pelo SARS-CoV-2, compartilhando dos sintomas da doença de Kawasaki, sem atuar como um desencadeante desta doença.
Palavras-chave
Abstract
Coronavirus disease 2019 (COVID-19) arose in December 2019 in China and quickly assumed great epidemiological importance, with an increasing number of cases and deaths in Brazil and worldwide. Among the several studies on this disease, cases of children infected with SARS-CoV-2 who had multisystem inflammation, mimicking Kawasaki disease, were reported, which raised the possibility of an association between Kawasaki disease and COVID-19. This review article aims to highlight this new diagnostic possibility and mainly discusses the symptoms, laboratory tests, and epidemiology that may differentiate multisystem inflammatory syndrome in children (MIS-C) as a result of COVID-19 or as a Kawasaki disease trigger. Original and review articles from 2020 and 2021 that were current and mentioned keywords such as coronavirus infections, mucocutaneous lymph node syndrome, and inflammation were selected from the electronic database PubMed. The review of MIS-C symptoms and laboratory findings related to COVID-19 was based on articles of studies that included more than 10 patients. The main results obtained were differences between the affected age group and ethnicity, presence of gastrointestinal tract symptoms, different mechanisms of cardiac injury involved, and changes in laboratory tests in Kawasaki disease and MIS-C. In conclusion, MIS-C is related to previous SARS-CoV-2 infection and leads to the same symptoms of Kawasaki disease, without acting as a trigger for this disease.
Keywords
Referências
1. Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health. 2020;13(5):667-3. doi: 10.1016/j.jiph.2020.03.019. Epub 2020 Apr 8. PMID: 32340833; PMCID: PMC7142680.
2. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30. PMID: 32007143; PMCID: PMC7135076.
3. Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281-6. doi: 10.1007/s12098-020-03263-6. Epub 2020 Mar 13. PMID: 32166607; PMCID: PMC7090728.
4. WHO. Coronavirus disease (COVID-19): How is it transmitted? [Internet]. Who.int. 2020. Acessado em: 26/12/2020. Disponível em: https://www.who.int/emergencies/diseases/novel-coronavirus2019/question-and-answers-hub/q-a-detail/q-a-how-is-covid-19- transmitted.
5. UNA-SUS. Organização Mundial de Saúde declara pandemia do novo Coronavírus [Internet]. Gov.br. 2020. Acessado em: 26/12/2020. Disponível em: https://www.unasus.gov.br/noticia/organizacaomundial-de-saude-declara-pandemia-de-coronavirus.
6. WHO. WHO Coronavirus Disease Dashboard [Internet]. Acessado em: 22/01/2021. Disponível em: http://
7. Simpson JM, Newburger JW. Multi-System Inflammatory Syndrome in Children in Association with COVID-19. Circulation. 2020 Jun 11. doi: 10.1161/CIRCULATIONAHA.120.048726. Epub ahead of print. PMID: 32525700.
8. Marchesi A, Tarissi de Jacobis I, Rigante D, Rimini A, Malorni W, Corsello G, et al. Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase. Ital J Pediatr. 2018;44(1):102. doi: 10.1186/s13052-018-0536-3. PMID: 30157897; PMCID: PMC6116535.
9. Doença de Kawasaki [Internet]. Hospital Sabará. Acessado em: 22/01/2021. Disponível em: https://www.hospitalinfantilsabara.org. br/sintomas-doencas-tratamentos/doenca-de-kawasaki/.
10. Jindal AK, Pilania RK, Prithvi A, Guleria S, Singh S. Kawasaki disease: characteristics, diagnosis, and unusual presentations. Expert Rev Clin Immunol. 2019 Oct;15(10):1089-104. doi: 10.1080/1744666X.2019.1659726. Epub 2019 Oct 1. PMID: 31456443.
11. Xu S, Chen M, Weng J. COVID-19 and Kawasaki disease in children. Pharmacol Res. 2020 Sep;159:104951. doi: 10.1016/j.phrs.2020.104951. Epub 2020 May 25. PMID: 32464327; PMCID: PMC7247462.
12. Koné-Paut I, Cimaz R. Is it Kawasaki shock syndrome, Kawasakilike disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic. RMD Open. 2020 Jun;6(2):e001333. doi: 10.1136/rmdopen-2020-001333. PMID: 32611651; PMCID: PMC7425186.
13. Rowley AH. Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children. Nat Rev Immunol. 2020;20(8):453-4. doi: 10.1038/s41577-020-0367-5. PMID: 32546853; PMCID: PMC7296515.
14. Jiao FY. Kawasaki disease - a new manifestation of COVID-19 in children. Zhongguo Dang Dai Er Ke Za Zhi. 2020 Jul;22(7):677-8. Chinese. doi: 10.7499/j.issn.1008-8830.2005117. PMID: 32669159; PMCID: PMC7389629.
15. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020 May 23;395(10237):1607-8. doi: 10.1016/ S0140-6736(20)31094-1. Epub 2020 May 7. PMID: 32386565; PMCID: PMC7204765.
16. Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020 Jun 6;395(10239):1771-8. doi: 10.1016/S0140-6736(20)31103-X. Epub 2020 May 13. PMID: 32410760; PMCID: PMC7220177.
17. Berezin E. Síndrome inflamatória multissistêmica pediátrica (síndrome associada temporalmente ao covid-19) [Internet]. Sociedade de Pediatria de São Paulo. 2020. Acessado em: 22/01/2021. Disponível em: http://
18. Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020 Jun 3;369:m2094. doi: 10.1136/bmj.m2094. PMID: 32493739; PMCID: PMC7500538.
19. Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS. Association between a novel human coronavirus and Kawasaki disease. J Infect Dis. 2005 Feb 15;191(4):499-502. doi: 10.1086/428291. Epub 2005 Jan 14. PMID: 15655771; PMCID: PMC7199489.
20. Alunno A, Carubbi F, Rodríguez-Carrio J. Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin. RMD Open. 2020 May;6(1):e001295. doi: 10.1136/rmdopen-2020-001295. PMID: 32423970; PMCID: PMC7299508.
21. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017 Jul;39(5):529‑39. doi: 10.1007/s00281-017-0629-x. Epub 2017 May 2. PMID: 28466096; PMCID: PMC7079893.
22. Junior HS, Sakano TMS, Rodrigues RM, Eisencraft AP, Carvalho VELD, Schvartsman C, et al. Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view. J Pediatr (Rio J). 2020 Sep 11. doi: 10.1016/j. jped.2020.08.004. Epub ahead of print. PMCID: PMC7486073.
23. Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, et al. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19). Front Immunol. 2020 May 1;11:827. doi: 10.3389/fimmu.2020.00827. PMID: 32425950; PMCID: PMC7205903.
24. Recalcati S, Invernizzi P, Arosio P, Cairo G. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun. 2008;30(1-2):84-9. doi: 10.1016/j.jaut.2007.11.003. PMID: 18191543.
25. Webb K, Abraham DR, Faleye A, McCulloch M, Rabie H, Scott C; Cape Town MISC-Team. Multisystem inflammatory syndrome in children in South Africa. Lancet Child Adolesc Health. 2020;4(10):e38. doi: 10.1016/S2352-4642(20)30272-8. Epub 2020 Aug 21. PMID: 32835654; PMCID: PMC7442431.
26. Moraleda C, Serna-Pascual M, Soriano-Arandes A, Simó S, Epalza C, Santos M, et al. Multi-Inflammatory Syndrome in Children related to SARS-CoV-2 in Spain. Clin Infect Dis. 2020 Jul 25:ciaa1042. doi: 10.1093/cid/ciaa1042. Epub ahead of print. PMID: 32710613; PMCID: PMC7454331.
27. Grimaud M, Starck J, Levy M, Marais C, Chareyre J, Khraiche D, et al. Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Ann Intensive Care. 2020 Jun 1;10(1):69. doi: 10.1186/s13613-020-00690-8. PMID: 32488505; PMCID: PMC7266128.
28. Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N, et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis. 2020 Aug;79(8):999-1006. doi: 10.1136/annrheumdis-2020-217960. Epub 2020 Jun 11. PMID: 32527868; PMCID: PMC7299653.
29. Belot A, Antona D, Renolleau S, Javouhey E, Hentgen V, Angoulvant F, et al. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Euro Surveill. 2020 Jun;25(22):2001010. doi: 10.2807/1560-7917.ES.2020.25.22.2001010. PMID: 32524957; PMCID: PMC7336112.
30. Belhadjer Z, Méot M, Bajolle F, Khraiche D, Legendre A, Abakka S, et al. Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic. Circulation. 2020 Aug 4;142(5):429-436. doi: 10.1161/ CIRCULATIONAHA.120.048360. Epub 2020 May 17. PMID: 32418446.
31. Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA. 2020 Jul 21;324(3):259-269. doi: 10.1001/ jama.2020.10369. PMID: 32511692; PMCID: PMC7281356.
32. Davies P, Evans C, Kanthimathinathan HK, Lillie J, Brierley J, Waters G, et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health. 2020 Sep;4(9):669-677. doi: 10.1016/S2352-4642(20)30215-7. Epub 2020 Jul 9. Erratum in: Lancet Child Adolesc Health. 2020 Jul 17;: PMID: 32653054; PMCID: PMC7347350.
33. Ramcharan T, Nolan O, Lai CY, Prabhu N, Krishnamurthy R, Richter AG, et al. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital. Pediatr Cardiol. 2020 Oct;41(7):1391-401. doi: 10.1007/s00246-020-02391-2. Epub 2020 Jun 12. PMID: 32529358; PMCID: PMC7289638.
34. Hameed S, Elbaaly H, Reid CEL, Santos RMF, Shivamurthy V, Wong J, et al. Spectrum of Imaging Findings at Chest Radiography, US, CT, and MRI in Multisystem Inflammatory Syndrome in Children Associated with COVID-19. Radiology. 2021 Jan;298(1):E1-E10. doi: 10.1148/radiol.2020202543. Epub 2020 Jun 25. PMID: 32584166; PMCID: PMC7769068.
35. Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Overcoming COVID-19 Investigators; CDC COVID19 Response Team. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. 2020 Jul 23;383(4):334‑6. doi: 10.1056/NEJMoa2021680. Epub 2020 Jun 29. PMID: 32598831; PMCID: PMC7346765.
36. Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, et al. New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team. Multisystem Inflammatory Syndrome in Children in New York State. N Engl J Med. 2020 Jul 23;383(4):347-58. doi: 10.1056/NEJMoa2021756. Epub 2020 Jun 29. PMID: 32598830; PMCID: PMC7346766.
37. Capone CA, Subramony A, Sweberg T, Schneider J, Shah S, Rubin L, et al. Characteristics, Cardiac Involvement, and Outcomes of Multisystem Inflammatory Syndrome of Childhood Associated with severe acute respiratory syndrome coronavirus 2 Infection. J Pediatr. 2020 Sep;224:141-5. doi: 10.1016/j.jpeds.2020.06.044. Epub 2020 Jun 14. PMID: 32553873; PMCID: PMC7293762.
38. Cheung EW, Zachariah P, Gorelik M, Boneparth A, Kernie SG, Orange JS, et al. Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City. JAMA. 2020 Jul 21;324(3):294-6. doi: 10.1001/ jama.2020.10374. PMID: 32511676; PMCID: PMC7281352.
39. Godfred-Cato S, Bryant B, Leung J, Oster ME, Conklin L, Abrams J, et al. COVID-19-Associated Multisystem Inflammatory Syndrome in Children - United States, March-July 2020. MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1074-80. doi: 10.15585/mmwr.mm6932e2. PMID: 32790663; PMCID: PMC7440126.
40. Kaushik S, Aydin SI, Derespina KR, Bansal PB, Kowalsky S, Trachtman R, et al. Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City. J Pediatr. 2020 Sep;224:24-9. doi: 10.1016/j.jpeds.2020.06.045. Epub 2020 Jun 14. PMID: 32553861; PMCID: PMC7293760.
41. Riollano-Cruz M, Akkoyun E, Briceno-Brito E, Kowalsky S, Reed J, Posada R, et al. Multisystem inflammatory syndrome in children related to COVID-19: A New York City experience. J Med Virol. 2020 Jun 25:10.1002/jmv.26224. doi: 10.1002/jmv.26224. Epub ahead of print. PMID: 32584487; PMCID: PMC7361761.
42. Miller J, Cantor A, Zachariah P, Ahn D, Martinez M, Margolis KG. Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases. Gastroenterology. 2020 Oct;159(4):1571-4.e2. doi: 10.1053/j.gastro.2020.05.079. Epub 2020 Jun 4. PMID: 32505742; PMCID: PMC7270806.
43. Lee PY, Day-Lewis M, Henderson LA, Friedman KG, Lo J, Roberts JE, et al. Distinct clinical and immunological features of SARSCoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020 Nov 2;130(11):5942-50. doi: 10.1172/JCI141113. PMID: 32701511; PMCID: PMC7598077.
44. Malviya A, Mishra A. Childhood Multisystem Inflammatory Syndrome: An Emerging Disease with Prominent Cardiovascular Involvement-A Scoping Review. SN Compr Clin Med. 2021 Jan 7:1-12. doi: 10.1007/ s42399-020-00650-0. Epub ahead of print. PMID: 33437929; PMCID: PMC7790313.
45. Kabeerdoss J, Pilania RK, Karkhele R, Kumar TS, Danda D, Singh S. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatol Int. 2021 Jan;41(1):19-32. doi: 10.1007/s00296-020-04749-4. Epub 2020 Nov 21. PMID: 33219837; PMCID: PMC7680080.
46. Feng Z, Bao Y, Yang Y, Zheng Y, Shen K. Severe acute respiratory syndrome coronavirus 2-induced multisystem inflammatory syndrome in children. Pediatr Investig. 2020 Dec 28;4(4):257-62. doi: 10.1002/ped4.12225. PMID: 33376953; PMCID: PMC7768297.
47. Kaushik A, Gupta S, Sood M, Sharma S, Verma S. A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection. Pediatr Infect Dis J. 2020 Nov;39(11):e340-e346. doi: 10.1097/INF.0000000000002888. PMID: 32925547.
48. Ahmed M, Advani S, Moreira A, Zoretic S, Martinez J, Chorath K, et al. Multisystem inflammatory syndrome in children: A systematic review. EClinicalMedicine. 2020 Sep;26:100527. doi: 10.1016/j.eclinm.2020.100527. Epub 2020 Sep 4. PMID: 32923992; PMCID: PMC7473262.
49. Radia T, Williams N, Agrawal P, Harman K, Weale J, Cook J, et al. Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation. Paediatr Respir Rev. 2020 Aug 11:S1526-0542(20)30117-2. doi: 10.1016/j.prrv.2020.08.001. Epub ahead of print. PMID: 32891582; PMCID: PMC7417920.
50. Yasuhara J, Kuno T, Takagi H, Sumitomo N. Clinical characteristics of COVID-19 in children: A systematic review. Pediatr Pulmonol. 2020 Oct;55(10):2565-75. doi: 10.1002/ppul.24991. Epub 2020 Aug 4. PMID: 32725955.
Submetido em:
24/02/2021
Aceito em:
25/03/2021
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email